FARAH NABIL; SALEEM, M. First-Line FOLFIRINOX vs Gemcitabine ± Nab-Paclitaxel in Metastatic Pancreatic Adenocarcinoma: Real-World Treatment Response and Clinicopathologic Predictors from a 2022 Tertiary-Center Cohort. Middle Eastern Cancer and Oncology Journal, v. 2, n. 2, p. 11–17, 19 Apr.2026.